Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-08

Clinical Trial Update: Neuroprotective Effect of Vitamin B12 and Vitamin B6 Against Vincristine Induced Peripheral Neuropathy [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the neuroprotective effect of Vitamin B12 and Vitamin B6 against vincristine-induced peripheral neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin B12 (cobalamin)
  • Vitamin B6 (pyridoxine)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Vincristine Induced Peripheral Neuropathy (VIPN) | Phase 4 | Status: COMPLETED